Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by SquishyIncon Oct 26, 2017 7:51pm
115 Views
Post# 26865832

RE:RE:RE:RE:RE:Average orders per day now at 1137

RE:RE:RE:RE:RE:Average orders per day now at 1137I'd be curious to hear your opinion (or anybody who wants to chime in), on the value of the data set being collected vs actual sales and revenue growth. Obviously med mj sales are going to plateau somewhat as we approach legalization. I say obviously considering myself. I'm not a large consumer, so when i had my script i maxed it out and have a bunch of dried out but awesome bud any time i want it. That being said, i'm dying to try Mettrum Yellow and Argyle oils, and I suspect many people are starting to hold off on renewing scripts because of the annoyance associated with renewal until that magical day. Anyhoo, i've completely strayed from my point, but curious if anybody else sees the value in knowing what people are purchasing vs the cumulative quantity.
ChacenAces wrote: Lol. I’ll take prime minister....I don’t envy the cluster muck that is congress my family in Cali has to live with.

I’m always around reading but truthfully It’s hard to participate with all the moronic posters and then even the reasonable ones who reply to them...makes this board a cluster muck as well. No matter how many I block I keep seeing them because people can’t seem to get it that all you have to do is ignore them and they go elsewhere for attention.

the order trajectory is definitely upward steadily for the last 4 quarters. We may see 20 mil this Q2 report on November 14th but surely in Q2. Al in all Canopy is on track for 80-100 million yearly with medical only so add exports, foreign grow ops, product partnerships yet to be allowed and of course rec and all is good.

SquishyInc wrote: Chacen for President! Thanks mang, been a while since we've heard from you. I'm encouraged by the stabilization of the order numbers, and think we'll see a nice gradual uptrend of the same as time goes on, especially considering the increasing consistency of product availablility. And really, we're like, 6-8 months away from rec sales. I suspect we'll see a substantial uptick in order numbers at that point, which will throw a real F into our projections. ;D

ChacenAces wrote: I haven't broken into that yet but a few points to consider which I think are very positive given that it is looking more and more like we could see Royal Accent, and thus mail order rec well before July of next year.

1) I check lot release dates randomly but enough to get a feel for the cycles. The store is now showing pretty consistently lots for sale that were released 5 to 7 months prior tonhittingbthe shelf. This is exactly what you want. To stay on top and increase market share an LP needs to be selling today what it grew at least one but preferably two quarters ago. In this fashion you keep selection high to onboard new patients while loading inventory for future rec and wholesale supply deals.

2) Its after croptober where we will see massive gains on inventory as the full Niagra greenhouse crop shows up.

Free55dom wrote: Chace, thanks for all the hard work. Anyone want to take a stab at how much added inventory will be put in the vaults for Q2. My guess would be approx 2100kg sold and 2100-3600kg added to inventory? I think production has ramped up Q2.
We are lisenced to produce 32,000kg a year, not sure if that has been increased. That means we should be able to produce 8000kg per Q, This is what we need to start seeing in order to prove the company can expand quik enough to meet rec demand. JMO

GLTA,

Free55dom

ChacenAces wrote: Average orders per day now sitting at 1137 for Q3/18. This has ramped up from the begining of the Q and is now essentially on pace with the previous Q2/18 which ended with an 1138 a erage per day. At this pace we should see a further ramp up by the end of the Q.

Ask and ye shall recieve Buck ;)

Here is the spread sheets for the last 2 quarters:

Canopy Average Orders Spreadsheets

 

 

 






Bullboard Posts